Circadian and behavioral factors of cardiovascular risk
心血管风险的昼夜节律和行为因素
基本信息
- 批准号:7114283
- 负责人:
- 金额:$ 49.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-09-15 至 2009-08-31
- 项目状态:已结题
- 来源:
- 关键词:biological clocksbiomarkerblood cell countblood pressurebody temperaturecardiovascular disorder riskcatecholaminescircadian rhythmsclinical researchcortisolelectrocardiographyexerciseheart ratehuman subjectplatelet aggregationpolysomnographyposturepsychological stressorsleepvascular endotheliumvasodilationwakefulness
项目摘要
DESCRIPTION (provided by applicant): Numerous epidemiological studies have established that there is a disproportionately high frequency of adverse cardiovascular events around 9 AM (e.g., sudden cardiac death, myocardial infarction). The mechanisms have been loosely attributed to behavioral stressors occurring at specific times of day (e.g., change in posture or activity). But, the independent role of the internal body clock (circadian pacemaker) in this day/night pattern has never been studied with appropriate techniques. Our preliminary data show a marked endogenous circadian rhythm in some markers of cardiovascular risk that may be implicated in the day/night pattern of adverse cardiovascular events. Thus, we have two Specific Aims: (1) Determine the effect upon cardiovascular risk markers of the circadian pacemaker (independent from behaviors); (2) Determine the interaction between circadian and behavioral influences upon cardiovascular risk markers (i.e., an interaction by which behavioral stressors have different effects at different circadian phases). To achieve these aims, we will utilize an intensive 12-day "Forced Desynchrony" protocol, wherein subjects' standardized behaviors and sleep occur at all phases of the circadian cycle. As this will be the first formal study in this area, we will begin by studying healthy individuals to define the normal human physiological rhythms and responses that could be implicated in the day/night pattern of cardiovascular risk. During the protocol standardized behavioral stressors include changes in posture (tilt table), activity (bicycle exercise) and sleep/wake state. The measures that can be implicated in triggering adverse cardiovascular events in vulnerable individuals, will include (i) autonomic nervous system activity (catecholamines, sympatho-vagal balance); (ii) hemodynamic factors (heart rate, blood pressure); (iii) Hemostatic factors (platelet aggregability and count); and (iv) vascular endothelial function (flow mediated vasodilatation). Based on preliminary data, we anticipate that behavioral stressors will have different effects at specific phases of the circadian cycle revealing vulnerable times for certain behaviors (likely corresponding to the peak in cardiovascular vulnerability from epidemiological studies). This project may ultimately help us to rationalize chronobiological therapies for cardiovascular diseases in terms of modification of behavior and timed pharmacological intervention.
描述(由申请人提供):许多流行病学研究表明,在上午9点左右,患不良心血管事件的频率不成比例(例如心脏猝死,心肌梗塞)。 这些机制已被松散地归因于在一天中特定时间发生的行为应力源(例如,姿势或活动的变化)。 但是,从来没有使用适当的技术研究了这一天/夜间模式中内部时钟(昼夜节奏起搏器)的独立作用。 我们的初步数据表明,在心血管风险的某些标志物中,内源性昼夜节律明显,可能与不良心血管事件的白天/夜间模式有关。 因此,我们有两个具体的目的:(1)确定对昼夜节奏起搏器心血管风险标记的影响(独立于行为); (2)确定昼夜节律对心血管风险标志物的影响(即行为应力源在不同昼夜节相的相互作用的相互作用)。 为了实现这些目标,我们将利用一个密集的为期12天的“强迫性”方案,其中受试者的标准化行为和睡眠发生在昼夜节律的所有阶段。 由于这将是该领域的首次正式研究,因此我们将首先研究健康的个体,以定义正常的人类生理节奏和反应,这可能与心血管风险的白天/夜晚模式有关。 在协议期间,标准化行为应力源包括姿势(倾斜表),活动(自行车运动)和睡眠/唤醒状态。 可能涉及触发脆弱个体的不良心血管事件的措施将包括(i)自主神经系统活动(儿茶酚胺,交感神经平衡); (ii)血液动力学因素(心率,血压); (iii)止血因子(血小板的聚集性和计数); (iv)血管内皮功能(流动介导的血管扩张)。 基于初步数据,我们预计行为压力源在昼夜节律周期的特定阶段会产生不同的影响,这揭示了某些行为的脆弱时间(可能与流行病学研究中心血管脆弱性的峰值相对应)。 该项目最终可能会帮助我们在行为修改和定时药理干预方面合理化心血管疾病的时间生物学疗法。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The human endogenous circadian system causes greatest platelet activation during the biological morning independent of behaviors.
- DOI:10.1371/journal.pone.0024549
- 发表时间:2011
- 期刊:
- 影响因子:3.7
- 作者:Scheer FA;Michelson AD;Frelinger AL 3rd;Evoniuk H;Kelly EE;McCarthy M;Doamekpor LA;Barnard MR;Shea SA
- 通讯作者:Shea SA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVEN A SHEA其他文献
STEVEN A SHEA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVEN A SHEA', 18)}}的其他基金
Endogenous circadian mechanisms underlying cardiovascular risk
心血管风险的内源性昼夜节律机制
- 批准号:
10438560 - 财政年份:2021
- 资助金额:
$ 49.65万 - 项目类别:
Endogenous circadian mechanisms underlying cardiovascular risk
心血管风险的内源性昼夜节律机制
- 批准号:
10656183 - 财政年份:2021
- 资助金额:
$ 49.65万 - 项目类别:
Sleep and Circadian Mechanisms Contributing to Disparity in Prevalence of Hypertension between Black and White Americans
睡眠和昼夜节律机制导致美国黑人和白人之间高血压患病率的差异
- 批准号:
9921998 - 财政年份:2018
- 资助金额:
$ 49.65万 - 项目类别:
Sleep and Circadian Mechanisms Contributing to Disparity in Prevalence of Hypertension Between Black and White Americans
睡眠和昼夜节律机制导致美国黑人和白人之间高血压患病率的差异
- 批准号:
9921461 - 财政年份:2018
- 资助金额:
$ 49.65万 - 项目类别:
Circadian Mechanisms in Progression of Obstructive Apnea in Humans
人类阻塞性呼吸暂停进展的昼夜节律机制
- 批准号:
7589472 - 财政年份:2009
- 资助金额:
$ 49.65万 - 项目类别:
Circadian Mechanisms in Progression of Obstructive Apnea in Humans
人类阻塞性呼吸暂停进展的昼夜节律机制
- 批准号:
7841754 - 财政年份:2009
- 资助金额:
$ 49.65万 - 项目类别:
Chronobiology of cardiovascular and pulmonary disease
心血管和肺部疾病的时间生物学
- 批准号:
6909786 - 财政年份:2004
- 资助金额:
$ 49.65万 - 项目类别:
相似国自然基金
基于Bacillus subtilis 细胞传感器介导的肠道环境中结直肠癌相关生物标志物的动态检测策略
- 批准号:82372355
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于肝癌多组学数据集成的肝癌生物标志物智能解析与预测方法研究
- 批准号:62333018
- 批准年份:2023
- 资助金额:237 万元
- 项目类别:重点项目
“微生物-肠-脑轴”调节抑郁症睡眠障碍的机制及其作为rTMS治疗效果预测的生物标志物研究
- 批准号:82371928
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
长牡蛎体内砷形态转化的剂量-效应关系、发生机制及生物标志物研究
- 批准号:42306158
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于多源异构数据融合与知识补全策略的证候生物标志物知识图谱构建方法研究
- 批准号:82305439
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Targeting PLK1 in RAS mutant chronic myelomonocytic leukemia
RAS 突变型慢性粒单核细胞白血病中的靶向 PLK1
- 批准号:
10656778 - 财政年份:2023
- 资助金额:
$ 49.65万 - 项目类别:
Novel risk stratification score for patients presenting with acute Cerebral Venous Sinus Thrombosis
急性脑静脉窦血栓形成患者的新风险分层评分
- 批准号:
10592974 - 财政年份:2023
- 资助金额:
$ 49.65万 - 项目类别:
HER1-3 and Death Receptor protein folding as therapeutic vulnerabilities
HER1-3 和死亡受体蛋白折叠作为治疗漏洞
- 批准号:
10721930 - 财政年份:2023
- 资助金额:
$ 49.65万 - 项目类别:
Deep-learning Integration of Histopathology and Proteogenomics at a Pan-cancer Level - Resubmission
泛癌水平上组织病理学和蛋白质基因组学的深度学习整合 - 重新提交
- 批准号:
10606760 - 财政年份:2023
- 资助金额:
$ 49.65万 - 项目类别:
A Novel Synthetic Biology-Derived Microbiome Therapeutic to Treat Viral-Induced Acute Respiratory Distress Syndrome (ARDS)
一种新型合成生物学衍生的微生物疗法,可治疗病毒引起的急性呼吸窘迫综合征(ARDS)
- 批准号:
10601865 - 财政年份:2023
- 资助金额:
$ 49.65万 - 项目类别: